Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
FMT With Bezlotoxumab in IBD Patients With Recurrent CDI
The addition of bezlotoxumab to fecal microbiota transplantation (FMT) does not provide any clear added benefit in patients with inflammatory bowel disease (IBD) and recurrent Clostridioides difficile infection (rCDI), according to a randomized controlled trial. “Given the high efficacy of FMT,…
English